Cargando…
Curative Cell and Gene Therapy for Osteogenesis Imperfecta
Osteogenesis imperfecta (OI) describes a series of genetic bone fragility disorders that can have a substantive impact on patient quality of life. The multidisciplinary approach to management of children and adults with OI primarily involves the administration of antiresorptive medication, allied he...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324990/ https://www.ncbi.nlm.nih.gov/pubmed/35306687 http://dx.doi.org/10.1002/jbmr.4549 |